Central effects of endothelin and its antagonists on sympathetic and cardiovascular regulation in SHR-SP

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 6, 1999, Pages 876-882

  Nakamura, Kazue ^a   Sasaki, Susumu ^a   Moriguchi, Jiro ^a   Morimoto, Satoshi ^a   Miki, Shigeyuki ^a   Kawa, Tetsuyoshi ^a   Itoh, Hiroshi ^a   Nakata, Tetsuo ^a   Takeda, Kazuo ^a   Nakagawa, Masao ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Blood pressure; Central nervous system; Endothelin; Endothelin receptor; Hypertension; Sympathetic nervous system

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; PHENTOLAMINE; RES 701 1;

ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; HEART INNERVATION; HEART RATE; HYPERTENSION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC INNERVATION; SYMPATHETIC TONE;

ANESTHESIA; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRAIN; ENDOTHELINS; HEART RATE; HYPERTENSION; INJECTIONS, INTRAVENTRICULAR; MALE; PEPTIDES, CYCLIC; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, WISTAR; RECEPTORS, ENDOTHELIN; SYMPATHETIC NERVOUS SYSTEM;

EID: 0032977585     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199906000-00007     Document Type: Article

References (36)

1. Garcia RM, Inagami T, Appalsamy M, Sugiura M, Robertson M. Endothelin as a neuropeptide: cardiovascular effects in the brainstem of normotensive rats. Circ Res 1992;72:20-35.
2. Koseki C, Imai M, Hirata Y, Yanagisawa M, Masaki T. Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide? Am J Physiol 1989;256:R858-66.
3. Lee ME, De la Monte SM, Ng SC, Bloch KD, Quertermous T. Expression of the potent vasoconstrictor endothelin in the human central nervous system. J Clin Invest 1990;86:141-7.
4. MacCumber MW, Ross CA, Glaser BM, Snyder SH. Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci USA 1989;86:7285-9.
5. Warner TD, Budzik GP, Mitchell JA, Huang ZJ, Murad F. Detection by bioassay and specific enzyme-linked immunosorbent assay of phosphoramidon-inhibitable endothelin converting activity in brain and endothelium. J Cardiovasc Pharmacol 1992;20(suppl 12):S19-21.
6. Hori S, Komatsu Y, Shigemoto R, Mizuno N, Nakanishi S. Distinct tissue distribution and cellular localization of the messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinology 1992;130:1885-95.
7. Nakamura K, Sasaki S, Morimoto S, et al. Central effects of endothelin and its antagonists in hypertensive rats. Fund Clin Pharmacol 1997:11(suppl 1):119s-20s.
8. Pellegrino LJ, Pellegrino AS, Cushman AJ. Stereotaxic atlas of the rat brain. New York: Appleton-Century-Crofts, 1979.
9. Yamamoto T, Kimura T, Ota K, et al. Central effects of endothelin-1 on vasopressin release, blood pressure, and renal solute excretion. Am J Physiol 1992;262:E856-62.
10. Kawano Y, Yoshida K, Yoshimi H, Matsuoka H, Omae T. Chronic effects of intracerebroventricular endothelin-1 on blood pressure and water and sodium handling in the rat. Hypertens Res 1994;17: 23-8.
11. Makino S, Hashimoto K, Hirasawa R, Hattori T, Ota Z. Central interaction between endothelin and brain natriuretic peptide on vasopressin secretion. J Hypertens 1992;10:25-8.
12. Gulati A, Kumar A, Shahani BT. Cardiovascular effects of centrally administered endothelin-1 and its relationship to changes in cerebral blood flow. Life Sci 1996;58:437-45.
13. Gulati A, Kumar A, Morrison S, Shahani BT. Effects of centrally administered endothelin agonists on systemic and regional blood circulation in the rat: role of sympathetic nervous system. Neuropeptides 1997;31:301-9.
14. Robinson MJ, Macrae IM, Todd M, Reid JL, McCullouch J. Reduction of local cerebral blood flow to pathological levels by endothelin-1 applied to the middle cerebral artery in the rat. Neurosci Lett 1990;118:269-72.
15. Garcia RM, Yates K, O'Leary J, Inagami T. Cardiovascular and respiratory effects of endothelin in the ventrolateral medulla of the normotensive rat. Hypertension 1995;26:263-71.
16. D'Amico M, Berrino L, Maione S, et al. Endothelin-I in rat periaqueductal gray area induces hypertension via glutamatergic receptors. Hypertension 1995;25(pt 1):507-10.
17. Samson WK, Murphy TC. Antidipsogenic actions of endothelins are exerted via the endothelin-A receptor in the brain. Am J Physiol 1993;265:R1212-5.
18. Gross PM, Zochodne DW, Wainman DS, Ho LT, Espinosa FJ, Weaver DF. Intraventricular endothelin-1 uncouples the blood flow: metabolism relationship in periventricular structures of the rat brain. Neuropeptides 1992;22:155-65.
19. Ferguson AV, Smith P. Circulating endothelin influences area postrema neurons. Regul Pept 1991;32:11-21.
20. Wall KM, Nasr M, Ferguson AV. Actions of endothelin at the subfornical organ. Brain Res 1992;570:180-7.
21. Gellai M, Fletcher T, Pullen M, Nambi P. Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat. Am J Physiol 1996;271:R254-61.
22. Rebello S, Roy S, Saxena PR, Gulati A. Systemic hemodynamic and regional circulatory effects of centrally administered endothelin-1 are mediated through ETA receptors. Brain Res 1995;676: 141-50.
23. Banasik JL, Hosick H, Wright JW, Hardin JW. Endothelin binding in brains of normotensive and spontaneously hypertensive rats. J Pharmacol Exp Ther 1991;257:302-6.
24. Gulati A, Rebello S. Characteristics of endothelin receptors in the central nervous system of spontaneously hypertensive rats. Neuropharmacology 1992;31:243-50.
25. Nishikibe M, Tsuchida S, Okada M, et al. Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model. Life Sci 1992;52:717-24.
26. Li JS, Schiffrin EL. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension 1995;25(pt 1):495-500.
27. Stasch JP, Dietrich CH, Frobel K, Wegner M. Prolonged endothelin blockade prevents hypertension and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Am J Hypertens 1995;8:1128-34.
28. Orth SR, Esslinger JP, Amann K, Schwarz U, Raschack M, Ritz E. Nephroprotection of an ETA-receptor blocker (LU 135252) in salt-loaded uninephrectomized stroke-prone spontaneously hypertensive rats. Hypertension 1998;31:995-1001.
29. Okada M, Fukuroda T, Shimamoto K, et al. Antihypertensive effects of BQ-123, a selective endothelin ETA receptor antagonist, in spontaneously hypertensive rats treated with DOCA-salt. Eur J Pharmacol 1994;259:339-42.
30. Kohno M, Murakawa K, Horio T, et al. Plasma immunoreactive endothelin-1 in experimental malignant hypertension. Hypertension 1991;18:93-100.
31. Schiffrin EL, Lariviére R, Li JS, Sventek P, Touyz RM. Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats. Hypertension 1995;25(pt 2):769-73.
32. Karam H, Heudes D, Bruneval P, et al. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Hypertension 1996;28:379-85.
33. Kato T, Kassab S, Wilkins FC, Kirchner KA, Keiser J, Granger JP. Endothelin antagonists improve renal function in spontaneously hypertensive rats. Hypertension 1995;25(pt 2):883-7.
34. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 1996;384:353-5.
35. Sharifi AM, He G, Touyz RM, Schiffrin EL. Vascular endothelin-1 expression and effect of an endothelin ETA antagonist on structure and function of small arteries from stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 1998;31(suppl 1): S309-12.
36. Nakajima M, Morimoto S, Takamoto S, et al. Endothelin-1 in cerebrospinal fluid in elderly patients with hypertension and dementia. Hypertension 1994;24:97-100.